11
dTIP leads collaboration in landmark AML treatment trial
At dTIP, we are proud to be a key partner in the RAPID trial, a ground-breaking initiative funded by PHRT to evaluate an ex-vivo drug testing platform developed by Snijder Lab, ETH Zurich. This trial approach, which aims to proof a (r)evolutionary treatment of acute myeloid leukaemia, has benefited from dTIP's extensive expertise.
National Future Day at dTIP
Young minds explore medical innovations